Browsing tag:

corona virus


confronting-drug-supply-chain-risks

The current coronavirus epidemic and subsequent shutdown of travel to and from affected areas in China make supply chain risk management a particularly timely topic this month. While the last thirty years have seen us grow increasingly comfortable with extended, global supply chains, these past few years’ (and months’) events have wreaked havoc on the[…]

Read More

LGM Pharma Acquires CDMO

On July 27, 2020, LGM Pharma announced its acquisition of the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. As a result, you will notice our new logo and visuals throughout the website. We’re working on updates to reflect the exciting, expanded CDMO capabilities and services we now can offer you.

This website uses cookies. By using our site, you agree to our terms of service